GleamWall
中文EN

CFOO China Foods Holdings Ltd.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—

Margins

Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%

Returns

ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x

Leverage & solvency

Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$2$253$88,788$96,828$142,214$41$183,319$22,403
Cost of revenue$0$24$83,281$87,958$126,654$16$150,937$21,088
Gross profit$2$229$5,507$8,870$15,560$25$32,382$1,315
SG&A expense$63,752$61,603$123,983$88,092$112,885$98,684$190,310$110,873
Operating income-$63,752-$61,598-$118,571-$79,256-$97,355-$103,741-$158,674-$110,669
Pretax income-$63,750-$61,597-$118,519-$79,246-$97,352-$103,555-$158,438-$110,630
Income tax$0———$0—$1$16,543
Net income-$63,750-$61,597-$118,519-$79,246-$97,352-$103,555-$158,439-$127,173
EBITDA-$62,000-$59,846-$116,816-$77,511-$95,613-$101,994-$157,100-$110,531
EPS (basic)0.000.00—0.000.00-0.01—-0.01
EPS (diluted)0.000.00—0.000.00-0.01—-0.01
Weighted avg. shares (diluted)20.25M20.25M—20.25M20.25M20.25M—20.25M
Banking
Net interest income$2$1$29$10$2$4$18$24
Balance sheet
Cash & equivalents$15,923$9,806$9,893$76,861$63,569$23,623$39,192$65,565
Inventory$40,407$39,737$39,255$45,634$98,238$78,502$54,943$70,530
Current assets$173,897$163,956$162,943$250,545$317,872$427,313$398,686$251,198
PP&E, net$24,708$26,217$27,860$29,346$30,858$32,557$34,264$16,859
Intangibles$1,465$1,562$1,662$1,751$1,856$1,949$2,055$2,259
Total assets$215,549$209,707$212,890$281,642$350,586$461,819$435,005$270,316
Current liabilities$1.63M$1.54M$1.48M$1.43M$1.41M$1.42M$1.29M$966,078
Total liabilities$1.63M$1.55M$1.49M$1.43M$1.41M$1.42M$1.29M$966,078
Shareholders' equity-$1.41M-$1.34M-$1.28M-$1.15M-$1.06M-$954,953-$850,807-$695,762
Shares outstanding20.25M20.25M20.25M20.25M20.25M20.25M20.25M20.25M
Cash flow statement
Operating cash flow-$93,772-$55,933-$133,340-$69,298-$85,743-$100,870-$152,134-$85,928
Capital expenditure——————$19,285$0
Free cash flow——————-$171,419-$85,928
Investing cash flow——————-$19,285$0
Financing cash flow$110,626$56,924$76,891$95,165$130,607$85,942$141,377$81,154
Depreciation & amortization$1,752$1,752$1,755$1,745$1,742$1,747$1,574$138

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.